treatment two-
Sponsors
Bio-innova and Synchron Co., Ltd., Bio-innova and Synchron.Co.,Ltd
Conditions
Bioequivalence study in healthy volunteers
Bioequivalence
ApixabanBioequivalence study in healthy volunteers.
Bioequivalence,
Phase 1
SINGLE DOSE CROSSOVER FULLY REPLICATE BIOEQUIVALENCE STUDY OF ATORVASTATIN CALCIUM TABLETS 80 MG IN HEALTHY, ADULT, HUMAN SUBJECTS UNDER FASTING CONDITION
Active, not recruitingTCTR20170109003
Start: 2017-05-09Updated: 2026-03-30
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Apixaban Film-coated tablets (5 mg) relative to Originator Apixaban Film-coated tablets (5 mg) in healthy Thai volunteers under fasting condition
Active, not recruitingTCTR20180308002
Start: 2018-05-02Target: 30Updated: 2026-03-30